Today in News History

On July 12, several notable moments in the history of News stand out. In 1580, The Ostrog Bible, one of the early printed Bibles in a Slavic language, is published. In 1813, Claude Bernard, French physiologist and academic (died 1878) was born. In 1849, William Osler, Canadian physician and author (died 1919) was born. In 1863, Albert Calmette, French physician, bacteriologist, and immunologist (died 1933) was born. In 1928, Elias James Corey, American chemist and academic, Nobel Prize laureate was born. In 1945, Boris Galerkin, Russian mathematician and engineer (born 1871) passed away. In 1952, Irina Bokova, Bulgarian politician, Bulgarian Minister of Foreign Affairs was born. In 1997, Malala Yousafzai, Pakistani-English activist, Nobel Prize laureate was born. In 1998, Arkady Ostashev, Soviet/Russian scientist and engineer (born 1925) passed away. In 2014, Valeriya Novodvorskaya, Russian journalist and politician (born 1950) passed away. Together, these milestones provide historical context for today's news news and ongoing narratives.

Turkish scientists pioneer search for next-gen antibiotics

Daily Sabah

Daily Sabah

·

June 26, 2026

·

right
Turkish scientists pioneer search for next-gen antibiotics

Imagine one day you come down with a simple infection, and the antibiotic prescribed by your doctor stops working. While this may sound like a far-fetched scenario, it is a reality...

Narrative Intelligence Brief

This article was published by Daily Sabah, a source frequently categorized with a right bias based in Turkey. Our narrative intelligence engine continuously monitors coverage from this outlet to track framing, bias, and rhetorical patterns. Our initial algorithmic scan of this specific piece did not flag high-confidence rhetorical techniques, suggesting a generally straightforward reporting style or neutral framing. By understanding the editorial perspective of Daily Sabah, readers can better contextualize the information presented and compare it across our broader media matrix to find the real narrative.

Analysis Methodology
This narrative analysis was generated using the CoDataLab Global Intelligence Engine. Our proprietary AI scans thousands of cross-border sources to identify sentiment patterns, framing techniques, and potential media bias. While AI provides the data-driven foundation, our objective is to empower readers with additional context beyond the standard headline.The content displayed above is a structured summary designed for rapid information processing. For the full original report, please visit the source outlet.

How other outlets are covering this story

Compare narratives across 6 related reports from 6 sources. Real Narrative News aggregates the coverage spectrum so you can see who emphasises what — bias tags reflect the outlet, not the story.

Coverage bias distribution

6 sources

Left 17%

Center 33%

Right 17%


Mexico News Daily

center

· Jul 6, 2026

Mexican researcher Nora Vázquez Laslop helps drive breakthrough antibiotic discovery

The research project that brought together scientists from Canada, the United States, Germany and Mexico identified a novel antibiotic that weakens the ability of harmful bacteria to develop resistance to it. The post Mexican researcher Nora Vázquez Laslop helps drive breakthrough antibiotic discovery appeared first on Mexico News Daily

NaturalNews.com

right

· Jun 28, 2026

Antibiotic resistance and E. coli: The hidden crisis fueling inflammatory bowel disease

(NaturalNews) The reckless overuse of broad-spectrum antibiotics, driven by Big Pharma's profit motive and corruption within medical and agricultural systems, h...

Ars Technica

Unknown

· Jun 26, 2026

Antibiotic "megacluster" discovery provides new strategy to fight superbugs

It's an exciting advance in efforts to restock the antibiotic arsenal.

Quartz

lean left

· Jul 10, 2026

Abivax CEO says $920M raise lets it launch its bowel disease drug in the U.S. solo

The French biotech plans to use proceeds to commercialize obefazimod in the U.S. through 2029, CEO Marc de Garidel told CNBC

The korea Herald News

center

· Jul 7, 2026

Matica Bio, VaxDome partner on antiviral hybrid vaccine development

Matica Biotechnology, the US contract development and manufacturing organization subsidiary of CHA Biotech, has partnered with Texas-based VaxDome Inc. to jointly develop an antigen-agnostic antiviral vaccine aimed at protecting against a broad range of infectious diseases. The collaboration will focus on advancing VaxDome's hybrid antiviral vaccine candidates into clinical trials. Under the agreement, Matica Biotechnology will provide process development, analytical development and the producti

https://cdn.mos.cms.futurecdn.net/cy3EaoYNYuMmyAABkL6RyN.jpg

· Jun 29, 2026

Japan's bold experiment to curb antibiotic misuse has been a huge success. Could it work in the US?

Japan's bold experiment to curb antibiotic misuse has been a huge success. Could it work in the US?

Topics:

World · 2
Health · 1
Technology · 1
Business · 1

Related coverage for "Turkish scientists pioneer search for next-gen antibiotics": Mexico News Daily — Mexican researcher Nora Vázquez Laslop helps drive breakthrough antibiotic discovery. NaturalNews.com — Antibiotic resistance and E. coli: The hidden crisis fueling inflammatory bowel disease. Ars Technica — Antibiotic "megacluster" discovery provides new strategy to fight superbugs. Quartz — Abivax CEO says $920M raise lets it launch its bowel disease drug in the U.S. solo. The korea Herald News — Matica Bio, VaxDome partner on antiviral hybrid vaccine development. https://cdn.mos.cms.futurecdn.net/cy3EaoYNYuMmyAABkL6RyN.jpg — Japan's bold experiment to curb antibiotic misuse has been a huge success. Could it work in the US?